Department of Hematology, Sultan Qaboos University Hospital, Muscat, Oman.
Department of Hematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Hemoglobin. 2020 Jan;44(1):20-26. doi: 10.1080/03630269.2020.1720709. Epub 2020 Feb 5.
α-Thalassemia (α-thal) is the most common autosomal recessive hemoglobinopathy. There is a vast diversity and geographical variability in underlying genotypes in Hb H (β4) patients. Herein, we describe the genotypes found in the largest report of Omani Hb H patients. Moreover, we reviewed and summarized the literature published from the Eastern Mediterranean region. A retrospective review of all genetically confirmed Hb H disease patients diagnosed between 2007 and 2017 at Sultan Qaboos University Hospital, Muscat, Oman, was performed. Hematological parameters and clinical presentations were assessed. Both α-globin genes were screened for deletional and nondeletional mutations using a stepwise diagnostic strategy as described before. A total of 52 patients (27 females and 25 males) with a mean age of 20.6 years (range 0.23-80.0) were molecularly confirmed to carry Hb H disease. The patients had a hemoglobin (Hb) level of 9.3 g/dL (range 5.7-13.0) and mean corpuscular volume (MCV) of 58.4 fL (range 48.2-82.1). A total of eight genotype combinations were identified, with α2 polyadenylation signal mutation (polyA1) (AATAA>AATAA (αα/αα), often cited as αα/αα, being the most common (53.8%) followed by -α/- - (28.8%). Our cohort also included patients with combinations of α with other Hb variants: αα/αα with Hb S (: c.20A>T) trait ( = 2), -α/αα ( = 2) and αα (: c.56delG)/αα ( = 1). Nondeletional Hb H disease due to the α mutation is the most common in Omanis. Molecular diagnosis is necessary for accurate confirmation of the diagnosis of α-thal, determination of underlying genotypes, follow-up and counseling.
α-地中海贫血(α-thal)是最常见的常染色体隐性血红蛋白病。在 Hb H(β4)患者的潜在基因型中,存在着广泛的多样性和地理变异性。在此,我们描述了在阿曼最大的 Hb H 患者报告中发现的基因型。此外,我们回顾并总结了来自东地中海地区发表的文献。对 2007 年至 2017 年在阿曼马斯喀特苏丹卡布斯大学医院诊断的所有经基因确认的 Hb H 疾病患者进行了回顾性分析。评估了血液学参数和临床表现。使用逐步诊断策略对两个α-珠蛋白基因进行缺失和非缺失突变的筛查,如前所述。共有 52 名患者(27 名女性和 25 名男性),平均年龄为 20.6 岁(范围为 0.23-80.0),经分子确认为携带 Hb H 疾病。患者的血红蛋白(Hb)水平为 9.3g/dL(范围为 5.7-13.0),平均红细胞体积(MCV)为 58.4fL(范围为 48.2-82.1)。共鉴定出 8 种基因型组合,其中α2 多聚腺苷酸化信号突变(polyA1)(AATAA>AATAA(αα/αα)最常见(53.8%),其次为-α/-(28.8%)。我们的队列还包括与其他血红蛋白变异体组合的患者:αα/αα与 Hb S(: c.20A>T)特征( = 2)、-α/αα( = 2)和 αα(: c.56delG)/αα( = 1)。由于α突变导致的非缺失性 Hb H 疾病在阿曼人中最为常见。分子诊断对于准确确认α-thal 诊断、确定潜在基因型、随访和咨询是必要的。